OBJECTIVE: To determine whether children with homozygous sickle cell anemia (SCD) who have silent infarcts on magnetic resonance imaging (MRI) of the brain are at increased risk for overt stroke. METHODS: We selected patients with homozygous SCD who (1) enrolled in the Cooperative Study of Sickle Cell Disease (CSSCD) before age 6 months, (2) had at least 1 study-mandated brain MRI at age 6 years or older, and (3) had no overt stroke before a first MRI. MRI results and clinical and laboratory parameters were tested as predictors of stroke. RESULTS: Among 248 eligible patients, mean age at first MRI was 8.3 +/- 1.9 years, and mean follow-up after baseline MRI was 5.2 +/- 2.2 years. Five (8.1%) of 62 patients with silent infarct had strokes compared with 1 (0.5%) of 186 patients without prior silent infarct; incidence per 100 patient-years of follow-up was increased 14-fold (1.45 per 100 patient-years vs 0.11 per 100 patient-years, P =.006). Of several clinical and laboratory parameters examined, silent infarct was the strongest independent predictor of stroke (hazard ratio = 7.2, P =.027). CONCLUSIONS: Silent infarct identified at age 6 years or older is associated with increased stroke risk.
OBJECTIVE: To determine whether children with homozygous sickle cell anemia (SCD) who have silent infarcts on magnetic resonance imaging (MRI) of the brain are at increased risk for overt stroke. METHODS: We selected patients with homozygous SCD who (1) enrolled in the Cooperative Study of Sickle Cell Disease (CSSCD) before age 6 months, (2) had at least 1 study-mandated brain MRI at age 6 years or older, and (3) had no overt stroke before a first MRI. MRI results and clinical and laboratory parameters were tested as predictors of stroke. RESULTS: Among 248 eligible patients, mean age at first MRI was 8.3 +/- 1.9 years, and mean follow-up after baseline MRI was 5.2 +/- 2.2 years. Five (8.1%) of 62 patients with silent infarct had strokes compared with 1 (0.5%) of 186 patients without prior silent infarct; incidence per 100 patient-years of follow-up was increased 14-fold (1.45 per 100 patient-years vs 0.11 per 100 patient-years, P =.006). Of several clinical and laboratory parameters examined, silent infarct was the strongest independent predictor of stroke (hazard ratio = 7.2, P =.027). CONCLUSIONS: Silent infarct identified at age 6 years or older is associated with increased stroke risk.
Authors: Olubusola B Oluwole; Robert B Noll; Daniel G Winger; Olu Akinyanju; Enrico M Novelli Journal: Pediatr Blood Cancer Date: 2016-07-09 Impact factor: 3.167
Authors: John J Strouse; Christiane S Cox; Elias R Melhem; Hanzhang Lu; Michael A Kraut; Alexander Razumovsky; Kaleb Yohay; Peter C van Zijl; James F Casella Journal: Blood Date: 2006-03-14 Impact factor: 22.113
Authors: Mboka Jacob; Dawn E Saunders; Jamie M Kawadler; Balowa Mussa; Russell Murdoch; Winok Lapidaire; Furahini Tluway; Ramadhan R Kazema; Siana Nkya; Magda Ahmed; Edward Kija; Lulu Fundikira; Frank Kussaga; Angela Darekar; Hilda Tutuba; Karin Shmueli; Christopher A Clark; Julie Makani; Fenella J Kirkham Journal: Blood Adv Date: 2018-11-30
Authors: Raffaella Colombatti; Giorgio Meneghetti; Mario Ermani; Marta Pierobon; Laura Sainati Journal: Ital J Pediatr Date: 2009-06-22 Impact factor: 2.638